You are here

Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Birmingham, Alabama, United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Parkinson Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
30 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Idiopathic Parkinson's disease

- Modified Hoehn and Yahr Scale Stages 1-4

- Age over 30 years

- Previous participation in prior sumanirole studies

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Use of dopamine agonist medications and other medications in defined timeframe

- Unstable dose of CNS active therapies (eg, hypnotics, antidepressants, anxiolytics)
within the last 30 days

- Atypical Parkinson's syndromes due to drugs, metabolic disorders, encephalitis, or
degenerative diseases

- Dementia

- History of active epilepsy within the past year

- Significant liver disease with defined laboratory criteria

- Significant renal disease with defined laboratory criteria

- Certain cardiac conditions

- Electroconvulsive therapy in the previous 90 days

- Subjects participating in other drug studies or receiving other investigational drugs
within previous 30 days

- Positive pregnancy test at Screen

- Unwillingness to use adequate contraceptive methods

- Lactating women

- History of stereotaxic brain surgery

- Malignant melanoma or history of treated melanoma

NCT00036205
Pfizer
Terminated
Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now